Tag Archives: Laura Chico

Wedbush Believes Prevail Therapeutics (NASDAQ: PRVL) Won’t Stop Here

In a report released today, Laura Chico from Wedbush maintained a Buy rating on Prevail Therapeutics (PRVL – Research Report), with a price target of $22.00. The company’s shares closed last Friday at $18.20, close to its 52-week high of

Prevail Therapeutics Inc (PRVL) Gets a Buy Rating from Wedbush

In a report released yesterday, Laura Chico from Wedbush maintained a Buy rating on Prevail Therapeutics Inc (PRVL – Research Report), with a price target of $20.00. The company’s shares closed last Monday at $11.02. According to TipRanks.com, Chico is

Ultragenyx Pharmaceutical, Inc. (RARE) Receives a Buy from Wedbush

Wedbush analyst Laura Chico reiterated a Buy rating on Ultragenyx Pharmaceutical, Inc. (RARE – Research Report) yesterday and set a price target of $75. The company’s shares closed last Monday at $59.69. According to TipRanks.com, Chico has 0 stars on

Wedbush Keeps a Buy Rating on Millendo Therapeutics Inc (MLND)

Wedbush analyst Laura Chico reiterated a Buy rating on Millendo Therapeutics Inc (MLND – Research Report) yesterday and set a price target of $24. The company’s shares closed last Monday at $6.97, close to its 52-week low of $6.77. According

Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Natus Medical Inc (BABY)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (NASDAQ:VRTX) and Natus Medical Inc (NASDAQ:BABY) with bullish sentiments. Vertex Pharmaceuticals (VRTX) Raymond James analyst Laura Chico maintained a Buy

Raymond James Downgrades Bioverativ Inc to Hold

In a report released today, Laura Chico from Raymond James downgraded Bioverativ Inc (NASDAQ: BIVV) to Hold. The company’s shares closed yesterday at $103.79, close to its 52-week high of $104.30. According to TipRanks.com, Chico is a 4-star analyst with